Clinical Trial Update: Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update from Johns Hopkins University evaluating the combination of psilocybin and MDMA for Posttraumatic Stress Disorder, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)
• Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Posttraumatic Stress Disorder | Phase 1 | Status: RECRUITING